Alignment Healthcare CMO proposes 36,000-share sale
The planned sale is described as a sale-to-cover rather than a discretionary trade, with the final share count determined by withholding rates and the sale-date stock price.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alignment Healthcare, Inc. (ALHC) lists a proposed sale of 36,000 common shares by Hyong (Ken) Kim, M.D., its Chief Medical Officer, with an aggregate market value of $305,280 and an approximate sale date of October 6, 2026. The transaction is described as a sale-to-cover, not a discretionary trade; the actual number of shares sold will be determined by applicable tax withholding rates and the stock price at the time of sale. The shares were acquired through vesting of 85,034 restricted stock units on October 4, 2023, under the issuer’s 2021 Equity Incentive Plan.
Key Figures
Key Terms
sale-to-cover transaction financial
restricted stock units financial
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.